ALDOCK

Japan
Yamanashi, Yamanashi, Japan

Company profile

ALDOCK company profile

ALDOCK develops a groundbreaking risk test that will help in the early detection of cancer. The company is conducting research and development of risk tests that will help in the early detection of cancer. ALDOCK analyzes biomarker measurement results by machine learning to constantly improve inspection accuracy, and also construct an NGS analysis pipeline for that purpose. It provides a secure API / SDK that can be shared with other applications, as well as the inspection result can be confirmed by the user from the application.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2016-12-01

Headquarters

Country code
JP
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
3
Total equity funding
$716,569
Last funding
Seed / 2019-01-01
Last equity funding
Seed
Investors
2
Lead investors
2
Founders
1

Founders and investors

Founders

Mabuchi Shingo

Lead investors

Incubate FundLifetime Ventures

Investors

Incubate FundLifetime Ventures